Peroxiredoxin 6 differentially regulates acute and chronic cigarette smokemediated lung inflammatory response and injury

Experimental Lung Research

Volumn 36, Issue 8, 2010, Pages 451-462

  Sundar, Isaac K ^a   Chung, Sangwoon ^a   Hwang, Jae Woong ^a   Arunachalam, Gnanapragasam ^a   Cook, Suzanne ^a   Yao, Hongwei ^a   Mazur, Witold ^b   Kinnula, Vuokko L ^b   Fisher, Aron B ^c   Rahman, Irfan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antioxidants; Cigarette smoke; COPD; Inflammation; Oxidants; Prdx6

Indexed keywords

ANTIOXIDANT; CIGARETTE SMOKE; CYTOKINE; PEROXIREDOXIN 6;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; GENE OVEREXPRESSION; INFLAMMATION; INFLAMMATORY CELL; LUNG; LUNG EMPHYSEMA; LUNG INJURY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; WILD TYPE;

ACUTE DISEASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINE CCL2; CHRONIC DISEASE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIREDOXIN VI; PNEUMONIA; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 77958005314     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902141003754128     Document Type: Article

References (49)

1. Rahman I, Adcock IM: Oxidative stress and redox regulation of lung infammation in COPD. Eur Respir J. 2006;28:219-242.
2. Rahman I, MacNee W: Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol. 1999;277:L1067-L1088.
3. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI: 4-Hydroxy-2-nonenal, a spe-cifc lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:490-495.
4. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG: Reversing the inactivation of peroxiredoxins caused by cysteine sulfnic acid formation. Science. 2003;300:653-656.
5. Kang SW, Baines IC, Rhee SG: Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem. 1998;273:6303-6311.
6. Kinnula VL, Lehtonen S, Kaarteenaho-Wiik R, Lakari E, Paakko P, Kang SW, Rhee SG, Soini Y: Cell specifc expression of peroxiredoxins in human lung and pulmonary sarcoido-sis. Thorax. 2002;57:157-164.
7. Lehtonen ST, Markkanen PM, Peltoniemi M, Kang SW, Kinnula VL: Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. Am J Physiol Lung Cell Mol Physiol. 2005;288:L997-L1001.
8. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K: Per-oxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35-41.
9. Seo MS, Kang SW, Kim K, Baines IC, Lee TH, Rhee SG: Identifcation of a new type of mammalian peroxiredoxin that forms an intramolecular disulfde as a reaction intermediate. J Biol Chem. 2000;275:20346-20354.
10. Fisher AB, Dodia C, Manevich Y, Chen JW, Feinstein SI: Phos-pholipid hydroperoxides are substrates for non-selenium glu-tathione peroxidase. J Biol Chem. 1999;274:21326-21334.
11. Chen JW, Dodia C, Feinstein SI, Jain MK, Fisher AB: 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem. 2000;275:28421-28427.
12. Manevich Y, Reddy KS, Shuvaeva T, Feinstein SI, Fisher AB: Structure and phospholipase function of peroxiredoxin 6: iden-tifcation of the catalytic triad and its role in phospholipid substrate binding. J Lipid Res. 2007;48:2306-2318.
13. Lehtonen ST, Ohlmeier S, Kaarteenaho-Wiik R, Harju T, Paakko P, Soini Y, Kinnula VL: Does the oxidative stress in chronic obstructive pulmonary disease cause thiore-doxin/peroxiredoxin oxidation? Antioxid Redox Signal. 2008; 10:813-819.
14. Mo Y, Feinstein SI, Manevich Y, Zhang Q, Lu L, Ho YS, Fisher AB: 1-Cys peroxiredoxin knock-out mice express mRNA but not protein for a highly related intronless gene. FEBS Lett. 2003;555:192-198.
15. Kim TS, Dodia C, Chen X, Hennigan BB, Jain M, Feinstein SI, Fisher AB: Cloning and expression of rat lung acidic Ca(2+)-independent PLA2 and its organ distribution. Am J Physiol. 1998;274:L750-L761.
16. Lee SB, Ho JN, Yoon SH, Kang GY, Hwang SG, Um HD: Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phospho-inositide 3-kinase, and Akt. Mol Cells. 2009; 28:583-588.
17. 2-induced oxidative stress. J Cell Biochem. 2008;104:1274-1285.
18. Wang X, Phelan SA, Forsman-Semb K, Taylor EF, Petros C, Brown A, Lerner CP, Paigen B: Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxida-tive stress. J Biol Chem. 2003;278:25179-25190.
19. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB: Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic Biol Med. 2004;37:1736-1743.
20. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB: Per-oxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress. Antioxid Redox Signal. 2006;8:229-237.
21. Fisher AB, Dodia C, Yu K, Manevich Y, Feinstein SI: Lung phospholipid metabolism in transgenic mice overexpressing per-oxiredoxin 6. Biochim Biophys Acta. 2006;1761:785-792.
22. 2 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic Biol Med. 2003;35:1110-1120.
23. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB: Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol. 2006;34:481-486.
24. Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, Adenuga D, Rahman I: Cigarette smoke-mediated infamma-tory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1174-L1186.
25. Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, Jenkins RA, Moneyhun JH: Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol. 1994;6:79-93.
26. Witschi H, Oreffo VI, Pinkerton KE: Six-month exposure of strain A/J mice to cigarette sidestream smoke: cell kinetics and lung tumor data. Fundam Appl Toxicol. 1995;26:32-40.
27. Foronjy RF, Mercer BA, Maxfeld MW, Powell CA, D'Armiento J, Okada Y: Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res. 2005;31:547-562.
28. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM: Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J. 2005;25:250-258.
29. Kawakami M, Paul JL, Thurlbeck WM: The effect of age on lung structure in male BALB/cNNia inbred mice. Am J Anat. 1984;70:1-21.
30. Parameswaran H, Majumdar A, Ito S, Alencar AM, Suki B: Quantitative characterization of airspace enlargement in emphysema. J Appl Physiol. 2006;100:186-193.
31. Rahman I, Kode A, Biswas SK: Assay for quantitative determination of glutathione and glutathione disulfde levels using enzymatic recycling method. Nat Protoc. 2006;1: 3159-3165.
32. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I: Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;294:L478-L488.
33. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA: Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol. 2005;17:183-189.
34. Roede JR, Carbone DL, Doorn JA, Kirichenko OV, Reigan P, Petersen DR: In Vitro and in Silico Characterization of Perox-iredoxin 6 Modifed by 4-Hydroxynonenal and 4-Oxononenal. Chem Res Toxicol. 2008;21:2289-2299.
35. Foronjy RF, Mirochnitchenko O, Propokenko O, Lemaitre V, Jia Y, Inouye M, Okada Y, D'Armiento JM: Superoxide dismutase expression attenuates cigarette smoke-or elastase-generated emphysema in mice. Am J Respir Crit Care Med. 2006;173:623-631.
36. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB: An an-tisense oligonucleotide to 1-cys peroxiredoxin causes lipid per-oxidation and apoptosis in lung epithelial cells. J Biol Chem. 2002;277:49927-49934.
37. Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, Lentsch AB: Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G266-G274.
38. Avila PC, Kropotov AV, Krutilina R, Krasnodembskay A, Tomilin NV, Serikov VB: Peroxiredoxin V contributes to antiox-idant defense of lung epithelial cells. Lung. 2008;186:103-114.
39. Serikov VB, Leutenegger C, Krutilina R, Kropotov A, Pleskach N, Suh JH, Tomilin NV: Cigarette smoke extract inhibits expression of peroxiredoxin V and increases airway epithelial permeability. Inhal Toxicol. 2006;18:79-92.
40. Roede JR, Orlicky DJ, Fisher AB, Petersen DR: Overexpression of peroxiredoxin 6 does not prevent ethanol-mediated oxidative stress and may play a role in hepatic lipid accumulation. J Pharmacol Exp Ther. 2009;330:79-88.
41. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through an-tioxidant response elements. Biochem Biophys Res Commun. 1997;236:313-322.
42. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S: Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004;114:1248-1259.
43. Biteau B, Labarre J, Toledano MB: ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature. 2003;425:980-984.
44. Chang TS, Cho CS, Park S, Yu S, Kang SW, Rhee SG: Peroxiredoxin III, a mitochondrion-specifc peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem. 2004;279:41975-41984.
45. Findlay VJ, Tapiero H, Townsend DM: Sulfredoxin: a potential therapeutic agent? Biomed Pharmacother. 2005;59:374-379.
46. Rhee SG, Jeong W, Chang TS, Woo HA: Sulfredoxin, the cys-teine sulfnic acid reductase specifc to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological signifcance. Kidney Int Suppl. 2007;106:S3-S8.
47. Bae SH, Woo HA, Sung SH, Lee HE, Lee SK, Kil IS, Rhee SG: Induction of sulfredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid Redox Signal. 2009;11:937-948.
48. Singh A, Ling G, Suhasini AN, Zhang P, Yamamoto M, Navas-Acien A, Cosgrove G, Tuder RM, Kensler TW, Watson WH, Biswal S: Nrf2-dependent sulfredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med. 2009;46:376-386.
49. March TH, Wilder JA, Esparza DC, Cossey PY, Blair LF, Herrera LK, McDonald JD, Campen MJ, Mauderly JL, Sea-grave J: Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci. 2006;92:545-559.